Renal cancer
Conditions
Interventions
Group A:single-layer interrupted suture
Group B:double-layer continuous suture
Sponsors
Nanjing Drum Tower Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Men aged >=18 years and =90g/L. b. Neutrophils >=1.5*10^9/L. c. Platelet count >=100*10^9/L. d. Blood potassium >=3.5mmol/L. e. Liver function indicators: ALT, AST<=1.5 times the upper limit of normal (ULN), TBIL<=1.5ULN (except for subjects with documented Gilbert syndrome). (7) If the subject is willing to participate, the subject must sign an informed consent form (ICF) indicating that he/she understands the purpose and procedures of the study and is willing to participate in the study. Subjects must be willing to and abide by the prohibitions and restrictions specified in the study protocol.
Exclusion criteria
Exclusion criteria: (1) Patients who cannot tolerate robotic laparoscopic surgery. (2) Imaging examinations indicated patients with distant metastatic renal tumors (abdominal CT plain scan + enhancement, chest CT plain scan, ECT-bone scan, PET-CT, etc.). (3) Imaging examination indicated tumor invasion of the collection system or patients with hematuria symptoms. (4) Patients with RENAL tumor renal score >=10. (5) There are some benign diseases in the affected kidney, such as kidney stones, chronic pyelonephritis or other diseases that lead to reduced kidney function. (6) Previous history of surgical treatment of the affected kidney. (7) Concurrent with other tumors. (8) Have mental illness, and have difficulties in communicating with medical personnel. (9) Medically poorly controlled hypertension (systolic blood pressure >=160mmHg or diastolic blood pressure >=95 MMHG). (10) Active or symptomatic viral hepatitis or other chronic liver disease known to be infected with human immunodeficiency virus (HIV). (11) Clinically significant heart disease, including myocardial infarction or arterial thrombosis in the past 6 months; Severe or unstable angina; New York Heart Society grade III or IV heart disease; Atrial fibrillation or other arrhythmias that require treatment. (12) There are other circumstances that the researcher considers inappropriate to participate in this study.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Postoperative creatinine; | — |
Primary
| Measure | Time frame |
|---|---|
| Warm ischemia time; | — |
Countries
China
Contacts
Public ContactBo Jiang
Nanjing Drum Tower Hospital
Outcome results
None listed